eKare joins the NIH-led Diabetic Foot Consortium for Landmark Diabetic Foot Ulcer Research

Share Article

inSight® wound management platform selected by NIDDK to support data collection and clinical monitoring for its national initiative.

inSight® 3D wound management platform

eKare’s inSight® 3D wound management platform

"eKare’s inSight® will be uniformly utilized across the institutions for standardized data collection and monitoring of wound progression."

eKare has been selected after an open competition to join the prestigious Diabetic Foot Consortium (DFC) organized by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a branch of the National Institute of Health (NIH). The objective of the DFC is to establish an organizational framework at the national level to facilitate integrated clinical and translational research to improve outcomes for patients with diabetic foot ulcers (DFUs).

DFUs represent a significant quality of life issue for patients and cost about $13 billion nationally.(1) The DFC is prioritizing DFU research and accelerating the development and validation of wound biomarkers to improve prediction of outcomes. The consortium includes:

  • Indiana University
  • Stanford University
  • University of California – San Francisco
  • University of Miami
  • University of Michigan
  • University of Pittsburgh

eKare’s inSight®, a comprehensive 3D wound management system, will be uniformly utilized across the institutions for standardized data collection and monitoring of wound progression.

“An initiative of such breadth and rigor dedicated to diabetic foot ulcer research is unprecedented,” says Patrick Cheng, CEO of eKare. “eKare is honored to have been selected by NIDDK and join the Diabetic Foot Consortium to help spearhead breakthrough advancements in DFU research.”

About eKare
eKare Inc. is dedicated to the design and development of wound assessment solutions, including 3D wound dimensions and tissue classification capabilities, using the latest computer-vision and mobile technology. eKare's innovative technology is creating new possibilities in how we deliver wound care across the healthcare continuum, from inpatient hospital and skilled nursing facilities to ambulatory clinics and telemedicine. eKare's mission is to advance the science and delivery of wound care by leveraging mobile and sensor technologies to connect patients, providers, and industry.

The content in this release is the sole responsibility of the authors and does not necessarily represent the official views or imply endorsement of the National Institutes of Health.

1. Raghav A, Khan ZA, Labala RK, Ahmad J, Noor S, Mishra BK. Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always. Ther Adv Endocrinol Metab. 2018;9(1):29–31. doi:10.1177/2042018817744513.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patrick Cheng
eKare, Inc.
1 (844) 443-5273
Email >
Visit website